Patents by Inventor Gustavo Costa

Gustavo Costa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Calcium-magnesium aluminosilicate (CMAS) resistant thermal and environmental barrier coatings
    Patent number: 11958786
    Abstract: A barrier coating system may include a super alloy or ceramic matrix composite (CMC) substrate underneath a bond coat. The barrier coating system may also include a calcium-magnesium aluminosilicate (CMAS) resistant coating configured to protect metallic, or oxide-based or silicon based components in a harsh CMAS environment.
    Type: Grant
    Filed: November 28, 2017
    Date of Patent: April 16, 2024
    Assignee: UNITED STATES GOVERNMENT ADMINISTRATOR OF NASA
    Inventors: Dongming Zhu, Gustavo Costa
  • Recombinant antigens of porcine circovirus 2 (PCV-2) for vaccine formulations, diagnostic kit and use thereof
    Patent number: 9717785
    Abstract: The present invention relates to the preparation of the recombinant antigen of the viral capsid of Porcine circovirus 2 (PCV-2) and modifications thereof, upon expression in a prokaryotic system, purification in the monomer form, recovery of virus-like particles (VLPs) and their use in vaccine formulations, diagnostic kits and a system for quantifying in vaccine lots of the PCV-2 antigen by means of a capture ELISA assay. The antigens and vaccine formulations can be used in animal's immunization in programs for combatting PCV-2-associated diseases in conventional swine breeding systems, and represent alternatives to the commercially available vaccines. The ELISA kit can be used for testing the quality of commercial and/or experimental vaccines against PCV-2.
    Type: Grant
    Filed: January 23, 2014
    Date of Patent: August 1, 2017
    Assignees: FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE MG-FAPEMIG, UNIVERSIDADE FEDERAL DE VIÇOSA
    Inventors: Márcia Rogéria De Almeida, Abelardo Silva Junior, Juliana Lopes Rangel Fietto, Gustavo Costa Bressan, Rafael Locatelli Salgado, Thiago Souza Onofre, Mariana Costa Fausto, Pedro Marcus Pereira Vidigal, Sthefany Patareli Kalks, Josicelli Souza Crispim, Roberta Amaziles Silva Leite, Jackson de Andrade Teixeira, Natália Fialho Gonzaga, Tiago Jaquel Zilch, Luiz Fernando Lino De Souza, Amanda Martins De Cruz Souza, Antônio De Morais Monteiro
  • RECOMBINANT ANTIGENS OF THE PORCINE CIRCOVIRUS 2 (PCV-2) FOR VACCINE FORMULATIONS AND USE THEREOF
    Publication number: 20160015799
    Abstract: The present continuation-in-part of the Application BR 7 10 2013 001893 refers to the obtainment of the viral capsid recombinant antigen of the Porcine circovirus 2 (PCV-2) and modifications thereof, upon expression in prokaryotic system, recovery of virus-like particles (VLPs) and its use in vaccine formulations. The antigens and vaccine formulations can be used in the immunization of animals in control programs of the diseases associated with PCV-2 in conventional swine production systems and represent alternatives to vaccines available on the market.
    Type: Application
    Filed: October 5, 2015
    Publication date: January 21, 2016
    Inventors: Márcia Rogéria DE ALMEIDA, Abelardo Silva JUNIOR, Juliana Lopes Rangel FIETTO, Gustavo Costa BRESSAN, Rafael Locatelli SALGADO, Thiago Souza ONOFRE, Mariana Costa FAUSTO, Pedro Marcus Pereira VIDIGAL, Sthefany Patareli KALKS, Josicelli Souza CRISPIM, Roberta AMAZILES SILVA LEITE, Jackson de ANDRADE TEIXEIRA, Natália FIALHO GONZAGA, Tiago JAQUEL ZILCH, Luiz Fernando LINO DE SOUZA, Amanda Martins DE CRUZ SOUZA, Antônio DE MORAIS MONTEIRO
  • RECOMBINANT ANTIGENS OF PORCINE CIRCOVIRUS 2 (PCV-2) FOR VACCINE FORMULATIONS, DIAGNOSTIC KIT AND USE THEREOF
    Publication number: 20160000897
    Abstract: The present invention relates to the preparation of the recombinant antigen of the viral capsid of Porcine circovirus 2 (PCV-2) and modifications thereof, upon expression in a prokaryotic system, purification in the monomer form, recovery of virus-like particles (VLPs) and their use in vaccine formulations, diagnostic kits and a system for quantifying in vaccine lots of the PCV-2 antigen by means of a capture ELISA assay. The antigens and vaccine formulations can be used in animal's immunization in programs for combatting PCV-2-associated diseases in conventional swine breeding systems, and represent alternatives to the commercially available vaccines. The ELISA kit can be used for testing the quality of commercial and/or experimental vaccines against PCV-2.
    Type: Application
    Filed: January 23, 2014
    Publication date: January 7, 2016
    Inventors: Márcia Rogéria DE ALMEIDA, Abelardo Silva JUNIOR, Juliana Lopes Rangel FIETTO, Gustavo Costa BRESSAN, Rafael Locatelli SALGADO, Thiago Souza ONOFRE, Mariana Costa FAUSTO, Pedro Marcus Pereira VIDIGAL, Sthefany Patareli KALKS, Josicelli Souza CRISPIM, Roberta AMAZILES SILVA LEITE, Jackson de ANDRADE TEIXEIRA, Natália FIALHO GONZAGA, Tiago JAQUEL ZILCH, Luiz Fernando LINO DE SOUZA, Amanda Martins DE CRUZ SOUZA, Antônio DE MORAIS MONTEIRO